Cpl Biologicals Private Limited

Cpl Biologicals Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials and compliance.
CIN U01403GJ2009PTC056409 Incorporated 24 March 2009 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹8.01 Cr
▼ 6.00% YoY
EBITDA · FY 2025
*****
▼ 2.00% YoY
Net profit · FY 2025
*****
▼ 7.00% YoY
Authorised capital
₹95 Cr
Registered with MCA
Paid-up capital
₹45.27 Cr
Issued & subscribed
Open charges
None
Secured borrowings
Company age
17 yrs
Est. 2009
Employees · EPFO
24
Latest available

About Cpl Biologicals Private Limited

Data last updated: 10 January 2026

Cpl Biologicals Private Limited is a private limited company based in Ahmedabad, Gujarat, India, a subsidiary of Cadila Pharmaceuticals Limited. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 24 March 2009, the company has been in operation for over 17 years.

Registered with ROC Ahmedabad under CIN U01403GJ2009PTC056409.

Capital: an authorised share capital of ₹95 Cr and a paid-up capital of ₹45.27 Cr. Formerly known as Cpl Biologicals Limited. It is led by directors including Rajiv Rajiv Modi and Amitabha Banerjee.

Last AGM: 30 July 2025. Financial statements filed for year ended 31 March 2025. Office: 708 Cadila Corporate Campus Sarkhej – Dholka Road Bhat, Ahmedabad, Gujarat, India – 382210.

As per the financials filed for FY 2025, the company reported a revenue of ₹8.01 Cr, a decline of 6% compared to the previous year.

The company has a workforce of approximately 24 employees as per the latest available data. It operates as a subsidiary of Cadila Pharmaceuticals Limited.

The company is associated with 1 brand - Cpl Biologicals.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cplbio.com.

Company Details of Cpl Biologicals Private Limited
CIN U01403GJ2009PTC056409
Registration Number 056409
Incorporation Date 24 March 2009
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 July 2025
Date of Balance Sheet 31 March 2025
Parent Company Cadila Pharmaceuticals Limited
Compliance Status Active Compliant
Key People
Rajiv Rajiv Modi Director Amitabha Banerjee Director Rajiv Indravadan Modi Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    cplbio.com
  • Social Media
    **************
  • Registered Address
    708 Cadila Corporate Campus Sarkhej – Dholka Road Bhat, Ahmedabad, Gujarat, India – 382210
  • Industry
    Pharma, Drug Formulation & Development
Company report
Cpl Biologicals Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Cpl Biologicals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Cpl Biologicals Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Cpl Biologicals Private Limited

Cpl Biologicals Private Limited has one previous CIN (Corporate Identification Number): U01403GJ2009PLC056409. The current CIN is U01403GJ2009PTC056409, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U01403GJ2009PTC056409 Current
U01403GJ2009PLC056409 Previous

Associated Brands with Cpl Biologicals Private Limited

Cpl Biologicals Private Limited operates one associated brand: CPL Biologicals. These brands represent Cpl Biologicals Private Limited's diversified market presence and brand portfolio.

Brand Description Website
CPL Biologicals
Develops high-quality vaccines, biologics, and diagnostics using advanced biological technologies. cplbio.com

Competitors & Alternatives of Cpl Biologicals Private Limited

Brands and companies operating in the same space as Cpl Biologicals Private Limited include Merck, Roivant Sciences, AbbVie and 7 more.

Competitor Description Location Founded
Merck Merck Pharmaceutical products are manufactured and marketed worldwide. Kenilworth, United Kingdom, United Kingdom 1891
Roivant Sciences Roivant Sciences Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. New York, United States, United States 2014
AbbVie AbbVie Biopharmaceutical research and drug development are conducted globally by AbbVie. Chicago, United States, United States 2012
Lilly Lilly Traditional pharmaceutical medicines are developed for multiple health fields. United States 1876
Gilead Gilead Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others Foster City, United States, United States 1987
United Therapeutics United Therapeutics Treatments for chronic and life-threatening diseases are developed and commercialized. Silver Spring, United States, United States 1998
Roche Roche Pharmaceuticals and diagnostics kits are developed for various diseases. Basel, Switzerland, Switzerland 1896
Ascendis Pharma Ascendis Pharma Long-acting prodrug therapies are developed for endocrine and rare diseases. Hellerup, Denmark, Denmark 2007
MorphoSys MorphoSys Therapeutic antibodies for cancer and other diseases are developed. Planegg, Germany, Germany 1992
Vertex Pharmaceuticals Vertex Pharmaceuticals Developer of drugs for the treatment of multiple disorders United States 1989

Business Activity of Cpl Biologicals Private Limited

Cpl Biologicals Private Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including scientific research and development.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
M Professional, Scientific and Technical M5 Scientific research and development *********

Auditor Details of Cpl Biologicals Private Limited

Cpl Biologicals Private Limited is audited by MUKESH M. SHAH & CO. for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
MUKESH M. SHAH & CO. blur-value blur-value blur-value

Board of Directors of Cpl Biologicals Private Limited

Cpl Biologicals Private Limited is currently managed by 8 directors, with 24 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Rajiv Rajiv Modi
Also directs: Irm Energy Limited, La Vie Biologicals Private Limited, Cadila Pharmaceuticals Limited and 5 more
Director 04 Jul 2024 2 Years 0 Months Current
Amitabha Banerjee
Also directs: Cpl Holdings Llp, Irm Energy Limited, La Vie Biologicals Private Limited and 5 more
Director 19 Dec 2024 1 Years 6 Months Current
Rajiv Indravadan Modi
Also directs: Cpl Holdings Llp, Irm Energy Limited, La Vie Biologicals Private Limited and 5 more
Director 24 Mar 2009 17 Years 3 Months Current
Ramesh Ratilal Choksi
Also directs: La Vie Biologicals Private Limited, Cadila Pharmaceuticals Limited, Gig - Irm Glass Insulators Private Limited and 5 more
Director 03 Nov 2018 7 Years 8 Months Current
Showing 6 of 8 current directors. View all directors

Financials of Cpl Biologicals Private Limited FY 2025 filings available

Cpl Biologicals Private Limited reported revenue of ₹8.01 Cr (down 6% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
₹8.01 Cr ▼ -6%
Profit
***** ▼ -7%
EBITDA
***** ▼ -2%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Shareholding Pattern of Cpl Biologicals Private Limited

As of FY 2023, Cpl Biologicals Private Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.

2025
YEAR
38.19% Promoters
25.22% DII (Domestic Institutional)
10.28% FII (Foreign Institutional)
25.89% Public
2.42% Others
Shareholding Trend
Year 2025
Promoters 33.19%
DII 23.22%
FII 18.28%
Public 22.89%
Others 2.42%

Charges & Borrowings Cpl Biologicals Private Limited

Cpl Biologicals Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Cpl Biologicals Private Limited

Cpl Biologicals Private Limited has a workforce of 24 employees as of Mar 22, 2024.

Employee count
24
Active EPFO establishments
1
Employee growth
-7.69%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Cpl Biologicals Private Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Cpl Biologicals Private Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Cpl Biologicals Private Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Cpl Biologicals Private Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Cpl Biologicals Private Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Cpl Biologicals Private Limited

MSME Payment Delays by Cpl Biologicals Private Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Cpl Biologicals Private Limited

Subsidiaries & Group Companies of Cpl Biologicals Private Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Cpl Biologicals Private Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Cpl Biologicals Private Limited

MCA Filings & Documents of Cpl Biologicals Private Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Cpl Biologicals Private Limited

Activity
30 Jul 2025
Cpl Biologicals Private Limited last Annual general meeting of members was held on 30 Jul 2025 as per latest MCA records.
Activity
31 Mar 2025
Cpl Biologicals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Directors
11 Jan 2025
Seema Vikash Sharma was appointed as a Ceo on 11 Jan 2025 & has been associated with this company since 1 year 6 months.
Directors
11 Jan 2025
Pratik Kumarpal Shah was appointed as a Cfo on 11 Jan 2025 & has been associated with this company since 1 year 6 months.
Directors
19 Dec 2024
Amitabha Banerjee was appointed as a Director on 19 Dec 2024 & has been associated with this company since 1 year 6 months.
Directors
15 Nov 2024
Manju Balaram Batham was appointed as a Company Secretary on 15 Nov 2024 & has been associated with this company since 1 year 7 months.

Frequently Asked Questions about Cpl Biologicals Private Limited

Cpl Biologicals Private Limited is an active private limited company in the pharma sector based in Ahmedabad, Gujarat, India. It was incorporated on 24 March 2009 (17+ years old) and is registered under CIN U01403GJ2009PTC056409. The company has 24 employees.

Cpl Biologicals Private Limited reported revenue of ₹8.01 Cr for FY 2025 (down 6.00% YoY).

The current directors of Cpl Biologicals Private Limited are:

The primary industry of Cpl Biologicals Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Cpl Biologicals Private Limited can be reached at the registered office: 708 Cadila Corporate Campus Sarkhej – Dholka Road Bhat, Ahmedabad, Gujarat, India – 382210, or through the website cplbio.com.

The authorised capital is ₹95 Cr, and the paid-up capital is ₹45.27 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available